Andy Hill Presents NuVision Biotherapies at LSI Europe '23

NuVision Biotherapies is a biotechnology company seeking to develop cost-effective and high-quality regenerative therapies for ophthalmology.
Join Our Next Event
Partner with the leaders
shaping the future of
Medtech at LSI USA ‘26
March 16th - 20th, 2026
Waldorf Astoria, Monarch Beach
Speakers
Andy Hill
Andy Hill
CEO, NuVision Biotherapies